Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for ALR
49.97
-0.04 (-0.08%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 49.56 - 50.12
52 week 31.94 - 50.61
Open 50.11
Vol / Avg. 217,917.00/514,488.00
Mkt cap 4.23B
P/E     -
Div/yield     -
EPS -2.27
Shares 83.85M
Beta 1.93
Inst. own 94%
Apr 27, 2015
Q1 2015 Alere Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 12, 2015
Alere Inc Corporate Analyst Meeting
Mar 4, 2015
Alere Inc at Cowen Health Care Conference - Webcast
Feb 10, 2015
Q4 2014 Alere Inc Earnings Release
Feb 10, 2015
Q4 2014 Alere Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -6.88% -7.16%
Operating margin 7.81% 3.61%
EBITD margin - 19.16%
Return on average assets -1.62% -2.69%
Return on average equity -8.85% -13.39%
Employees 9,800 -
CDP Score - -

Address

51 Sawyer Rd Ste 200
WALTHAM, MA 02453-3448
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alere Inc. is a provider of point-of-care diagnostics and services. The Company�s portfolio includes a range of health information solutions and provides clinical decision support. The Company operates in four segments: professional diagnostics, health information solutions, consumer diagnostics, and corporate and other. The professional diagnostics segment includes a range of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions. The health information solutions segment provides integrated programs and services focused on wellness, disease and condition management, productivity enhancement and informatics. The consumer diagnostics segment consists of manufacturing operations related to its role as the manufacturer of products for SPD Swiss Precision Diagnostics (SPD).

Officers and directors

Namal Nawana President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
David Teitel Chief Financial Officer, Vice President, Treasurer
Age: 50
Bio & Compensation  - Reuters
Daniella Cramp Global President - cardiometabolic business unit
Age: 40
Bio & Compensation  - Reuters
Hilde Eylenbosch M.D. President - Alere International Limited
Age: 50
Bio & Compensation  - Reuters
Craig Keyes M.D. Global President - Alere Health Information Solutions
Age: 58
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 44
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease
Bio & Compensation  - Reuters
Paul T. Hempel Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary
Age: 65
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 67
Bio & Compensation  - Reuters
Carla R Flakne Chief Accounting Officer, Vice President
Age: 60
Bio & Compensation  - Reuters